Abiopharma

🔍 CONNELL EUGENE C (Director)

Company: ERIE INDEMNITY CO (ERIE)

Report Date: 2026-04-20

Detailed Transactions and Holdings:

• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-20 | Code: H | nature_of_ownership: By Children | shares_owned_after: 2,462.60 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-20 | Code: H | shares_owned_after: 17,433.25
• Acquired 39 shares of Directors' Deferred Compensation Share Credits (Derivative)
  Date: 2026-04-20 | Code: J | equity_swap_involved: 0 | shares_owned_after: 3,345.30 | transaction_form_type: 4 | Footnotes: F2, F3, F4, F4

Footnotes:

• F1: Shares held by Reporting Person's children living in his household. The Reporting Person disclaims beneficial ownership of these reported securities, therefore this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose.
• F2: Conversion price is not applicable to shares granted under the Outside Directors' Deferred Compensation Plan.
• F3: Acquired under Directors' Deferred Compensation Plan.
• F4: The shares subject to this reporting are Share Credits which are periodically credited to the accounts of certain Directors of Erie Indemnity Company pursuant to its Outside Directors' Stock Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual's service as a Director of the Company ends. There are no exercisable or expiration dates for these securities.